IDXX Stock Summary and Trading Ideas (Idexx Laboratories | NASDAQ:IDXX)

Idexx Laboratories primarily develops, manufactures, and distributes diagnostic products, equipment, and services for pets and livestock. Its key product lines include single-use canine and feline test kits that veterinarians can employ in the office, benchtop chemistry and hematology analyzers for test-panel analysis on-site, reference lab services, and tests to detect and manage disease in livestock. The firm also offers vet practice management software and consulting services to animal hospitals. Idexx gets close to 35% of its revenue from outside the United States.

Idexx Laboratories trades on the NASDAQ stock market under the symbol IDXX.

As of February 3, 2025, IDXX stock price climbed to $473.42 with 870,189 million shares trading.

IDXX has a beta of 1.19, meaning it tends to be more sensitive to market movements. IDXX has a correlation of 0.36 to the broad based SPY ETF.

IDXX has a market cap of $38.77 billion. This is considered a Large Cap stock.

In the last 3 years, IDXX traded as high as $583.39 and as low as $317.06.

The top ETF exchange traded funds that IDXX belongs to (by Net Assets): VTI, VOO, VO, QQQ, SPY.

IDXX has underperformed the market in the last year with a return of -8.1%, while SPY returned +25.6%. This shows that you would have done better investing in the overall market (through SPY) over the last year than in IDXX shares. However, IDXX has outperformed the market in the last 3 month and 2 week periods, returning +16.3% and +12.9%, while SPY returned +5.8% and +0.3%, respectively. This indicates IDXX has been having a stronger performance recently.

IDXX support price is $413.95 and resistance is $430.15 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that IDXX shares will trade within this expected range on the day.